Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chronomics has developed a commercialized bio-infrastructure platform that enables rapid integration of biomarker-based diagnostics into consumer and business products. The company initially focused on epigenetic testing but pivoted to become a major provider of validated at-home COVID‑19 saliva tests during the pandemic. Its current offerings include over a dozen at-home wellness tests covering areas such as heart health, thyroid function, vitamin levels, ovarian reserve/fertility assessment as well as its flagship epigenetics test measuring biological age via DNA methylation patterns. Over 100,000 customers have used its services as of late 2023.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chronomics.